According to the Zhitong Finance App, Shen Lian Biology (688098.SH) announced that on August 2, 2023, the company received a “Notice on the Progress of Implementation of the Share Holding Reduction Plan” from shareholder Shanghai Hongchao and its co-actor Shanghai Fenghong. From May 24 to August 2, 2023, Shanghai Hongchao and its co-actor Shanghai Fenghong reduced their holdings by a total of 6.154,900 shares, accounting for 1.5% of the company's total share capital. The amount of holdings reduced in this holdings reduction plan has been reduced by more than half, and the implementation of the holdings reduction plan has not yet been completed.
申联生物(688098.SH)股东上海泓潮及其一致行动人累计减持公司1.5%股份
Shanghai Hongchao, a shareholder of Shenlian Biotech (688098.SH), and its co-actors reduced their holdings of the company by 1.5% by a total of 1.5%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.